INTERNATIONAL PATENT: RENASCI BIOTECHNOLOGIES, INC. FILES APPLICATION FOR "GENOMIC EDITING METHODS TO TREAT CARDIOVASCULAR DISEASE AND COMPOSITIONS FOR USE IN PRACTICING THE SAME"

GENEVA, Nov. 5 -- RENASCI BIOTECHNOLOGIES, INC. (350 Cambridge Ave, Suite 300Palo Alto, California 94306) filed a patent application (PCT/US2025/026429) for "GENOMIC EDITING METHODS TO TREAT CARDIOVASCULAR DISEASE, AND COMPOSITIONS FOR USE IN PRACTICING THE SAME" on Apr 25, 2025. With publication no. WO/2025/227064, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUO, Lucie (350 Cambridge Ave, Suite 300Palo Alto, California 94306), SMITH, Stephen J. (350 Cambridge Ave, Suite 300Palo Alto, California 94306), WANG, Sean (35...